Dr. Sandra Crouse Quinn, a professor in the University of Maryland School of Public Health’s Department of Family Science and senior associate director of the Maryland Center for Health Equity, has been appointed as a member of The National Academies of Sciences, Engineering, and Medicine’s (National Academies) Committee on Evidence-Based Practices for Public Health Emergency Preparedness and Response. This committee falls within the Health and Medicine Division and its board on health sciences policy.
[Photo: Dr. Sandra Crouse Quinn]
Dr. Quinn’s record of research, teaching, and professional experience are a strong foundation for the committee’s tasks. She has received funding from the Centers from Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) on preparedness and response, including a CDC-funded study of postal workers and public health professionals in the 2001 anthrax attack; a CDC-funded study of public attitudes during the 2009 – 2010 H1N1 influenza pandemic; and an FDA-funded study of public understanding of medical countermeasures. She has extensive experience with teaching and training practitioners on crisis and emergency risk communication, and has been involved with multiple expert panels addressing risk communication, planning for scarce medical resources, FDA communications during an emergency and community resilience.
This committee is tasked with developing a comprehensive review and grading of existing evidence for public health emergency preparedness and response practices generated since September 11, 2001. The committee will draw from multiple sources to determine which of the 15 capabilities (Public Health Emergency Preparedness or “PHEP” capabilities) defined in the CDC’s Public Health Preparedness Capabilities: National Standards for State and Local Planning to prioritize for inclusion in the systematic review. The committee will also focus on practices applicable to state, territorial, local, and tribal public health preparedness and response practitioners.
Chaired by Dr. Ned Calonge, president and CEO of the Colorado Trust, the committee convened January 29 – 30 in Washington, DC, and expects its work to be completed in summer 2020. In response to her appointment, Dr. Quinn commented, “This committee tackles a vital task and in so doing, can contribute to a stronger public health system that is ready for an array of public health emergencies.”